This fourth edition of Fundamentals of Research Methodology for Healthcare Professionals has been updated to incorporate the latest trends in research methodology and evidence-based practice. It details the steps involved in planning and undertaking a research project, from identifying and formulating the problem through to reporting findings. It underscores the importance of having a clear understanding of research methodology and terminology for doing the following: reading research reports with critical insight, implementing evidence-based practice, and expanding research. This edition is certain to stimulate awareness of the myriad researchable and research-requiring questions encountered daily in healthcare practice. Key features include: - clearly defined learning objectives to indicate the focus of each chapter - practical examples of research projects or steps in the research process - chapter summaries to reinforce learning - exercises to put the theory into practice - a practical, hands-on introduction to research methodology.

This text is a review of molecular immunohematology (MI). It draws from analyses and case studies around the world and details many techniques used in many labs. It is aimed at anyone interested in how MI is changing blood bank and transfusion medicine.

Genetically-engineered mouse models for cancer research have become invaluable tools for studying cancer biology and evaluating novel therapeutic approaches. This volume focuses on state-of-the-art methods for generating, analyzing and validating such models for studying aspects of human cancer biology. Additionally, these models are emerging as important pre-clinical systems in which to test cancer prevention and therapeutic strategies in order to select compounds for testing in clinical trials.

Breast cancer remains a disease of considerable public health importance worldwide, with over 800,000 new cases diagnosed globally each year. Considerable energy is currently being spent by researchers to further our understanding of this complex disease, however, keeping up with all of the new data is a real challenge given the sheer volume of information that becomes available on a daily basis. The purpose of this book would be to provide a comprehensive review of breast cancer epidemiology, covering the topics of disease burden, etiology, risk factors, prevention, early detection/screening, treatment, and outcomes. The book would be a single comprehensive source of the most recent information on breast cancer epidemiology, and it would serve as a valuable resource for breast cancer researchers across disciplines regardless of what stage of their career they are in. To the knowledge of the editor, no such resource is currently available.

Written in a very simple and reader-friendly manner, this book can be used by laboratory personnel in the biological and chemical sciences. It addresses the difficulties students and scientific laboratory personnel have with translating chemical concepts into an in-lab practical preparation and description of solutions. Its step-by-step approach in describing pre-laboratory calculations and setups, and the preparation of solution at the bench, was designed to meet the needs of a wide range of laboratory personnel irrespective of their academic status. The provision of alternative methods and approaches presented in this book ensures that readers can choose an approach more suited to their needs and understanding.

Defined as red blood cell break down and the release of hemoglobin and intracellular contents into the plasma, haemolysis can seriously impact patient care as well as the laboratory's reputation through its affect on test results. Therefore, the European Preanalytical Scientific Committee, in collaboration with the International Federation of Clinical Chemistry Working Group on Patient Safety, have designed a questionnaire to collect data on prevalence and management of haemolytic specimens referred to the clinical laboratories for clinical chemistry testing. The new book will help identify the areas where haemolysis occurs most frequently, which can, in turn, guide further analysis about why it is occurring. Once these elements are known, practices and procedures can be implemented to dramatically reduce haemolysis and avoid erroneous laboratory results affecting patient care and increasing laboratory costs.

Weareenteringintoaneraofre-awakeningoftheimportanceandinterestinthe role ofaltered intermediary metabolisminthedevelopmentandprogressionof malignancy. Therefore, thisbookMitochondriaandCanceristimelyandrelevant tocontemporaryandfutureresearch, training, andeducation. Thehallmarkstudies ofOttoWarburgetal. (1926)sparkedtheeraoftumorcellmetabolism. Fromthen untilaround1980, studiesofintermediarymetabolismofnormalandmalignant cellsweremajorareasofresearchandofgraduateandpostgraduatetrainingin biomedicalsciences. Thisperiodwasdominatedbymitochondrialstudiesandby thoseextraordinaryoutstandingscientistswhowereaffectionatelyreferredtoasthe "mitochondriacs." However, theadvent, development, andsubsequentdominance ofmoleculargenetics/molecularbiologyandmoleculartechnologyinbiomedical researchwereaccompaniedbythenearlycompletesubmersionofinterestinareas ofintermediarymetabolismandtumorcellmetabolism. Forthepast30orsoyears, graduateandpostgraduatetraining, experienceandfocusinbiochemistry, meta- lism, enzymology, cellphysiologyhavedeclined, beingdisplacedbythedo- nanceofmoleculartechnologies. Therecentrevelationsandadvancesinmolecular genetics/molecularbiologyandthedevelopmentofmolecularandnanotechnology providenewdimensionstoapplytotheunderstandingandelucidationoftheroleof intermediarymetabolismandmitochondrialfunctioninthedevelopmentandp- gressionofcancers. Toaddresstheissuesoftumormetabolism, thepresentand futuregenerationsofresearchersmustintegratetheknowledgeandmethods of biochemistrywiththeknowledgeandtechnologyofmolecularbiology. Thefocusonmitochondriaiscentraltodiscussionsandissuesofintermediary metabolism. Thegenetictransformationofnormalfunctionalcellstoneoplastic cellsimposestheneedforalterationsinintermediarymetabolismandmitochond- alfunctiontoprovidethebioenergetic/synthetic/growthrequirementsforthep- gression of the neoplastic cell to malignancy. In the absence of the metabolic transformation, theneoplasticmalignantcellwillnotachieveitsmalignantpot- tial. Thus, itiscriticaltoestablishtheroleofthemitochondriainthemalignant process. Moreover, speci?calterationsindifferentcancertypesmustbeidenti?ed. Such information will provide new approaches to the treatment and perhaps preventionofdifferingcancers. TheadventofMetabolomicsforthedetectionof v vi Preface cancer and progression of malignancy is dependent upon the elucidation and identi?cationofalteredmetabolismandmitochondrialfunction. Thus, thisexciting journeyincancerresearchhasbarelybegunandhasalongwaytogo. Thisbook, Mitochondria and Cancer, and its subject matter provide a roadmap and the preparationtoproceedonthisjourney. Wearegreatlyindebtedtothecontributingauthorsfortheirenthusiasticsupport andwritingachapterintheirareaofexpertise. WearegratefultoMs. DonnaOvak for secretarial help and our families for their patience and support in putting togetherthisbook. Thisbookisdedicatedtopast, present, andfuture"mitoch- driacs"aroundtheworld. Buffalo, NY KeshavK. Singh Baltimore, MD LeslieC. Costello Contents MitochondriaandCancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 KjerstinM. Owens, J. S. Modica-Napolitano, andKeshavK. Singh WarburgandhisLegacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 MichaelRistowandTimJ. Schulz TheLipogenicSwitchinCancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 KoenBrusselmansandJohannesV. Swinnen CitrateMetabolisminProstateandOtherCancers . .

Point of care testing (POCT) is a new concept in laboratory medicine that is widely used at present. It is the new advent that helps ease medical care in the present day. The knowledge on the POCT medicine is very important and necessary for the general practitioner. In this specific book, the author summarizes, presents and discusses on the concept of POCT, its importance and examples of important POCT tools.

In a perfect world, after their clinical rotation, CLSs and MLTs will be working in all four areas of study of medical technology (Microbiology, Chemistry, Hematology and Immunohematology), retain all that they know and live and work happily ever after. But as we all know that is far from the case, more frequently than not, a CLS or MLT will be stuck in one or two specialized area of study. Mycology is a unique sub-subspecialty of Microbiology that both the macroscopic and microscopic part of it require years of experience for a CLS to feel a high level of confidence. CLSs who had been away from the Mycology department for a period of time or never had a chance to work in the Mycology department will need a good refresher course before venturing into this department. This manual does not claim to be able to boost someone's confidence overnight or claim to have all the answers, but instead this manual serves as a guide to re-discovering what one previously knew. My hope is that this manual will serve its purpose and be a source of confidence to those who are brave enough to venture out in the mycology department as a newbee or someone who had been away from it for a period of time.

With the first IVF treatments, many skeptics rejected the process due to the possibility of something going wrong. But with time, this new way of conceiving became accepted throughout the world. But there is always a danger that somebody might come up with an unethical and dangerous idea to influence the process of fetal development in order to be able to offer his or her services to the people who would be prepared to pay enormous sums and in this way endanger the lives of the innocent newborn.

With time and effort, some of the ideas, impossible today, might be achievable in the future and it could go beyond our present understanding but we should be on guard that it does not go beyond our control.

Organized alphabetically by test, this reference guide provides quick and reliable access to information on over 420 laboratory tests and diagnostic procedures. With additional information provided for each procedure and extensive nursing implications with client teaching material, this book is an invaluable resource for nursing students and professionals alike.

"Palko's Medical Laboratory Procedures, " third edition, teaches the theory, principles, and pathology behind testing procedures for laboratory personnel. This is a competency-based textbook and reference that also functions as a workbook and laboratory manual by providing Procedure Competency Checklists for a step-by-step guide to proper protocol. Safety and total quality assurance have been emphasized throughout the text and current HIPAA regulations are introduced when appropriate to the laboratory setting. It is current in the new lab procedures set by CLIA and OSHA, Universal Precautions, and quality control. The more knowledgeable the lab personnel and accuracy of the test results, the greater the care provided to the patient.

Increased intracellular levels of reactive oxygen species (ROS) may result in tissue damage and are therefore associated with various diseases, especially with cancer. Apart from their potentially harmful functions, ROS have been identified as important mediators of essential cellular processes like apoptosis. Antioxidants are the cellular antagonists of ROS and act to neutralize the cytotoxic impact of oxyradicals. In healthy individuals, antioxidant systems serve to maintain intracellular ROS levels below a certain threshold, permitting the functionality of essential ROS-mediated signaling processes but preventing ROS overproduction and potential tissue damage. Even small shifts of the ROS-antioxidant balance may entail serious biological consequences. In the context of ROS-based anti-cancer applications inducing apoptosis, the action of antioxidants may critically influence the outcome of the therapy. Decreased antioxidant capacity that is induced purposefully as a therapeutic strategy may result in an improved anti-cancer action, whereas the external addition of antioxidants may reduce the cytotoxic potential of the therapy.

Heart rejection is a major problem for heart transplant patients. The best strategy for understanding and preventing organ rejection is to study experimental animal models. The popular mouse model of heterotopic cardiac transplantation has been used for over three decades to help investigators understand the pathogenesis of graft rejection and in turn, how novel drugs can attenuate the immune response to transplanted organs. Also, since the genetic blueprint of mice is well-known, specific genes can be modified to study its effect on graft acceptance and tolerance. Despite the large potential for this model, little is known about the physiology, haemodynamics, and morphology of the transplanted heart and there is no method to assess objectively graft survival. This work describes in detail the use of high-frequency ultrasound for investigating the small transplanted mouse heart. For the first time, insights are made into blood flow, the effects of graft rejection, and organ survival with never before seen high-resolution images unachievable with conventional ultrasound. This work will be of significant interest to investigators, clinicians and students in the field.